Annual report pursuant to Section 13 and 15(d)

Convertible Debt - Related Party (Detail Textuals 1)

v3.19.1
Convertible Debt - Related Party (Detail Textuals 1)
1 Months Ended 12 Months Ended
Jan. 19, 2019
$ / shares
shares
Dec. 28, 2017
USD ($)
Day
$ / shares
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jan. 19, 2018
$ / shares
Short-term Debt [Line Items]          
Aggregate gross proceeds     $ 900,000    
Proceeds from convertible debt issuance     400,000 $ 500,000  
Convertible debt       $ 235,000  
Loss on extinguishment of debt     $ (590,392)    
Emerald Health Sciences Inc          
Short-term Debt [Line Items]          
Effective interest rate     13.94% 13.94%  
Emerald Health Sciences Inc | Subsequent Event          
Short-term Debt [Line Items]          
Initial conversion price | $ / shares $ 0.10        
Number of notes converted into common stock | shares 9,000,000        
Bridge Loan | Secured Promissory Note and Security Agreement | Emerald Health Sciences Inc          
Short-term Debt [Line Items]          
Aggregate gross proceeds   $ 900,000      
Bridge loan interest rate   12.00%      
Initial conversion price | $ / shares   $ 0.10     $ 0.10
Proceeds from convertible debt issuance   $ 500,000      
Funding of remaining bridge loan   400,000      
Convertible debt   265,000      
Additional conversion liability   $ 360,000      
Number of trading days as of financing close date | Day   1